skip to content

[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase I results of its oral GLP-1 receptor agonist CT-996 for the treatment of people with obesity

Investors

Investor updates
view all

stay updated

get the latest news and updates to your inbox.